Description and outcomes of a staff-assisted peritoneal dialysis program in the United States
Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis · 2025
DOI: 10.1177/08968608241259607 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis, 2025. Verfasst von Wael F Hussein und 8 weiteren Autor:innen. Beteiligte Einrichtung: Satellite Healthcare, San Jose, CA, USA. Hauptthemen laut MEDLINE: Peritoneal Dialysis, Kidney Failure, Chronic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben.
Abstract (Originalsprache)
Background
Staff-assisted peritoneal dialysis (PD) can help overcome barriers to self-care but is not yet available in the United States (US). We developed and implemented a staff-assisted PD program that fits within current regulatory and cost restraints in the US healthcare environment.
Methods
Patient care technicians (PCTs) were trained on PD procedures and troubleshooting common problems. The program expanded from two centers in August 2020 to sixteen by October 2022. We described the logistic elements of program delivery, and patient and treatment outcomes for patients discharged by end of April 2023, with a cohort follow up until October 2023.
Results
A total of 121 patients were referred to the program. The most common indications for referral were physical function limitations, cognitive impairment, and psychosocial challenges. Staff assistance was provided for 73 patients. Mean age was 72 (standard deviation 14) years. A total of 604 visits were delivered, with a median 5 (interquartile range [IQR] 3–10, range: 1–49) visits per patient. Median duration of assistance was 8 (IQR: 2–21, range: 1–84) days. Assistance was most frequently needed for PD treatment setup and for observing and directing the technique. No peritonitis events or exit-site infections were reported. Sixty-eight patients (93%) were discharged on PD without staff assistance. The 6- and 12-month survival of PD without assistance was 71% and 57%, respectively.
Conclusions
Staff-assisted PD for limited time periods is operationally feasible with PCTs in the US and can support transitioning and maintaining patients on PD. ClinicalTrials.gov Identifier: NCT04319185
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Satellite Healthcare, San Jose, CA, USA.
- Department of Medicine, Division of Nephrology, Stanford University School of Medicine, Palo Alto, CA, USA.
- School of Nursing and Midwifery, Griffith University, Brisbane, Australia.
- Department of Pharmaceutical Care and Health Systems, University of Minnesota, Minneapolis, MN, USA.
- Department of Nephrology, Kaiser Permanente Oakland Medical Center, The Permanente Medical Group, Oakland, CA, USA.
ORCID-Profile: Wael F Hussein
Zitieren
APA
Hussein, W. F., Chen, S., Bennett, P. N., Atwal, J., Abra, G., Weinhandl, E., Zheng, S., Pravoverov, L., & Schiller, B. (2025). Description and outcomes of a staff-assisted peritoneal dialysis program in the United States. Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis. https://doi.org/10.1177/08968608241259607
Vancouver
Hussein WF, Chen S, Bennett PN, Atwal J, Abra G, Weinhandl E, et al. Description and outcomes of a staff-assisted peritoneal dialysis program in the United States. Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis. 2025. doi:10.1177/08968608241259607
BibTeX
@article{Hussein2025,
author = {Hussein, Wael F and Chen, Shijie and Bennett, Paul N and Atwal, Jugjeet and Abra, Graham and Weinhandl, Eric and Zheng, Sijie and Pravoverov, Leonid and Schiller, Brigitte},
title = {Description and outcomes of a staff-assisted peritoneal dialysis program in the United States},
journal = {Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis},
year = {2025},
doi = {10.1177/08968608241259607}
}
EUVIMED